Remedicalizing an epidemic: From HIV treatment as prevention to HIV treatment is prevention

AIDS

Volumn 25, Issue 3, 2011, Pages 291-293

  Nguyen, Vinh Kim ^a   Bajos, Nathalie ^b,c   Dubois Arber, Françoise ^d   O'Malley, Jeffrey ^e   Pirkle, Catherine M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UN Program on Aging   (United States)

Author keywords

antiretroviral therapy; HIV; medicalisation; microbicides; politics of science; prevention; victim blaming

Indexed keywords

ANTIVIRUS AGENT; MICROBICIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONDOM; EPIDEMIC; GOVERNMENT; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; NOTE; PATIENT CARE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS LOAD; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EPIDEMICS; HIV INFECTIONS; HIV-1; HUMANS; PRIMARY PREVENTION;

EID: 79551576072     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283402c3e     Document Type: Note

References (14)

1. Seidel G. The competing discourses of HIV/AIDS in sub-Saharan Africa: discourses of rights and empowerment vs. discourses of control and exclusion. Social Sci Med 1993; 36:175-194.
2. Montaner JSG. Opening press conference. In XVIII International AIDS Conference. Vienna, Austria; 2010.
3. Hirschel B. Anti-HIV drugs for prevention. In XVIII International AIDS Conference. Vienna, Austria; 2010.
4. UNAIDS, WHO. 09 AIDS Epidemic Update. In Geneva; 2009.
5. Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet 2008; 372:475-488.
6. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376: 532-539.
7. Maggiolo F, Leone S. Is HAART modifying the HIV epidemic? Lancet 376:492-493.
8. Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sex Health 2008; 5:113-118.
9. Hamers FF, AM D. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet 2004; 364:83-94.
10. Scheer S, Kellogg T, Klausner JD, Schwarcz S, Colfax G, Bernstein K, et al. HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour. Sex Transm Infect 2008; 84:493-498.
11. Cohen MS. ART and HIV: treatment as prevention. In XVIII International AIDS Conference. Vienna, Austria; 2010.
12. Lima Viviane D, Johnston K, Hogg Robert S, Levy Adrian R, Harrigan PR, Anema A, Montaner Julio SG. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 198:59-67.
13. Surveillance and Risk Assessment Division. Summary: estimates of HIV prevalence and incidence in Canada, 2008. In Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2009.
14. Karim SA. Understanding HIV transmission mechanisms: microbicides and PrEP. In XVIII International AIDS Conference. Vienna, Austria; 2010.